Cyclodextrin for the treatment of lysosomal storage diseases
US11020422B2 · kind B2 · utility
1Cited by
6References
6Claims
0Family size
Inventors
Key dates
| Filing date | Jun 12, 2017 |
| Grant date | Jun 1, 2021 |
| Priority date | — |
| Expiry date | Jun 12, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides for methods of treating lysosomal storage disorders and/or reduction of non-cholesterol lipids, using cyclodextrin compounds, including in combination with other therapeutics, including vitamin E.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.